TR201903815T4 - Nanoyapılar ve bunların uygulamaları. - Google Patents

Nanoyapılar ve bunların uygulamaları. Download PDF

Info

Publication number
TR201903815T4
TR201903815T4 TR2019/03815T TR201903815T TR201903815T4 TR 201903815 T4 TR201903815 T4 TR 201903815T4 TR 2019/03815 T TR2019/03815 T TR 2019/03815T TR 201903815 T TR201903815 T TR 201903815T TR 201903815 T4 TR201903815 T4 TR 201903815T4
Authority
TR
Turkey
Prior art keywords
compositions
monomer residues
polymeric framework
middle portion
crosslinked
Prior art date
Application number
TR2019/03815T
Other languages
English (en)
Inventor
Axelsson Oskar
Bäckström Sania
Petoral Rodrigo Jr
Original Assignee
Spago Nanomedical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spago Nanomedical Ab filed Critical Spago Nanomedical Ab
Publication of TR201903815T4 publication Critical patent/TR201903815T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04—Polysiloxanes
    • C08G77/22—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen
    • C08G77/30—Polysiloxanes containing silicon bound to organic groups containing atoms other than carbon, hydrogen and oxygen phosphorus-containing groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Burada 8-100 nm'lik bir hidrodinamik çapa (Dh) sahip olan, bir orta kısım ve bir çevresel kısım içeren bir globüler nanoyapı açıklanmakta olup, burada; söz konusu orta kısım 6-90 nm'lik bir hesaplanmış çapa (Dc) sahiptir ve söz konusu çevresel kısım Dh=Dc+2Tp olacak şekilde tahmini bir kalınlığa (Tp) sahip olması, burada söz konusu orta kısım aşağıdaki unsurları içermektedir: (i) monomer kalıntıları içeren bir çapraz bağlı polimerik çerçeve, burada monomer kalıntılarının sayıca en az %30'u çapraz bağlanmaktadır böylelikle çapraz bağlı polimerik çerçeve oluşturmaktadır ve/veya (ii) monomer kalıntıları içeren bir dallanmış polimerik çerçeve, burada dal noktalarının sayısı monomer kalıntılarının en az %30'udur, burada söz konusu orta kısım en az 4'ü çok yüklü en az bir katyonun şelasyonuna olanak sağlayan şelatlayıcı gruplar içermektedir, burada söz konusu şelatlayıcı gruplar -COOR1, -P=O(OR1)(OR2) ve -S(=O)2OR1'den oluşan gruptan bağımsız olarak seçilmektedir, burada R1 ve R2, bir negatif yük, H, düşük alkiller ve arilden oluşan gruptan bağımsız olarak seçilmektedir ve burada söz konusu çevresel kısım orta kısma kovalent olarak eklenen bir sentetik polimer malzeme içermektedir, burada sentetik polimer malzeme hidrofilik ve biyoinerttür ve elektriksel olarak nötr veya zwitteriyoniktir. Ayrıca bu nanoparçacıkları ve opsiyonel olarak bir radyonüklidi içeren bileşimler, bu bileşimlerin kullanımı, bu bileşimleri içeren kitler ve bu bileşimleri elde etmeye yönelik yöntemler açıklanmaktadır.
TR2019/03815T 2014-03-28 2015-03-27 Nanoyapılar ve bunların uygulamaları. TR201903815T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14162399.1A EP2923712A1 (en) 2014-03-28 2014-03-28 Nanostructures and applications thereof

Publications (1)

Publication Number Publication Date
TR201903815T4 true TR201903815T4 (tr) 2019-04-22

Family

ID=50478704

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/03815T TR201903815T4 (tr) 2014-03-28 2015-03-27 Nanoyapılar ve bunların uygulamaları.

Country Status (14)

Country Link
US (1) US9999693B2 (tr)
EP (2) EP2923712A1 (tr)
JP (1) JP6707074B2 (tr)
KR (1) KR102347377B1 (tr)
CN (1) CN106232146B (tr)
AU (1) AU2015238208B2 (tr)
CA (1) CA2943852C (tr)
DK (1) DK3122383T3 (tr)
ES (1) ES2715885T3 (tr)
IL (1) IL248014B (tr)
PL (1) PL3122383T3 (tr)
RU (1) RU2684777C2 (tr)
TR (1) TR201903815T4 (tr)
WO (1) WO2015144891A1 (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3348560A1 (en) 2017-01-16 2018-07-18 Spago Nanomedical AB Chemical compounds for coating of nanostructures
CN112316151B (zh) * 2020-10-30 2023-01-13 天津大学 一种基于共价三嗪环骨架化合物的纳米载体及其制备方法
EP4241792A1 (en) 2022-03-08 2023-09-13 Spago Nanomedical AB Nanostructures and applications thereof
EP4241793A1 (en) 2022-03-08 2023-09-13 Spago Nanomedical AB Globular nanostructures
EP4241765A1 (en) 2022-03-08 2023-09-13 Spago Nanomedical AB Globular nanostructures having an anchoring layer
EP4242250A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Compounds for coating of nanostructures

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6803106B2 (en) 2002-04-16 2004-10-12 William Henry Campbell Multi-layered macromolecules and methods for their use
JP2004067703A (ja) 2002-04-24 2004-03-04 Japan Science & Technology Corp 架橋ポリマー、微粒子および製造方法
EP1578455A4 (en) 2002-11-04 2008-12-31 Biosphere Medical Inc POLYMER HYDROGEL MICROSPHERES ASSOCIATED WITH RADIOISOTOPES AND METHODS OF MAKING AND USING THE SAME
US20040258614A1 (en) 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
US20080095699A1 (en) * 2006-10-20 2008-04-24 Shiying Zheng Imaging contrast agents using nanoparticles
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
AU2008212556A1 (en) * 2007-02-07 2008-08-14 Spago Imaging Ab Visualization of biological material by the use of coated contrast agents
WO2009049089A1 (en) * 2007-10-09 2009-04-16 Washington University In St. Louis Ligand directed toroidal nanoparticles for therapy and diagnostic imaging
US20110027172A1 (en) * 2007-12-10 2011-02-03 Zhuang Wang Drug delivery system for pharmaceuticals and radiation
WO2009110936A2 (en) * 2007-12-28 2009-09-11 Spring Bioscience Corporation Antigen retrieval methods for immunohistochemistry
IE20080211A1 (en) 2008-03-20 2009-11-25 Nat Univ Ireland Biodegradable nanoshells for delivery of therapeutic and/or imaging molecules
US20110111033A1 (en) 2008-04-09 2011-05-12 Harald Stover Hydrogel with covalently crosslinked core
EP2210616A1 (en) * 2009-01-21 2010-07-28 Centre National de la Recherche Scientifique Multifunctional stealth nanoparticles for biomedical use
US8470891B2 (en) 2009-12-23 2013-06-25 International Business Machines Corporation Biodegradable block polymers for drug delivery, and methods related thereto
EP2572736A1 (en) 2011-09-23 2013-03-27 Spago Imaging AB Nanostructures comprising manganese
US9415123B2 (en) * 2011-10-10 2016-08-16 The Regents Of The University Of Michigan Polymeric nanoparticles for ultrasound imaging and therapy
US9555132B2 (en) 2012-06-20 2017-01-31 The Trustees Of The University Of Pennsylvania Water-soluble nanoparticles

Also Published As

Publication number Publication date
RU2016140159A (ru) 2018-04-28
EP3122383A1 (en) 2017-02-01
DK3122383T3 (en) 2019-04-08
US20170106105A1 (en) 2017-04-20
CA2943852A1 (en) 2015-10-01
WO2015144891A1 (en) 2015-10-01
CA2943852C (en) 2022-07-19
AU2015238208B2 (en) 2019-11-07
JP2017509708A (ja) 2017-04-06
CN106232146A (zh) 2016-12-14
CN106232146B (zh) 2019-07-30
PL3122383T3 (pl) 2019-08-30
KR20160137634A (ko) 2016-11-30
RU2016140159A3 (tr) 2018-10-08
RU2684777C2 (ru) 2019-04-15
ES2715885T3 (es) 2019-06-06
EP2923712A1 (en) 2015-09-30
KR102347377B1 (ko) 2022-01-07
BR112016022054A2 (pt) 2017-08-15
EP3122383B8 (en) 2019-03-13
AU2015238208A1 (en) 2016-09-29
JP6707074B2 (ja) 2020-06-10
US9999693B2 (en) 2018-06-19
IL248014B (en) 2018-07-31
EP3122383B1 (en) 2018-12-26

Similar Documents

Publication Publication Date Title
TR201903815T4 (tr) Nanoyapılar ve bunların uygulamaları.
BR112018075841A2 (pt) polímero biocompatível, hidrogel, dispositivo, biomaterial e método de preparação do hidrogel
BR112014006683A2 (pt) nanoestrutura que compreende íons de manganês; composição farmacêutica; uso de uma nanopartícula; e nanoestrutura
WO2017209823A3 (en) Injectable pastes based on oppositely charged polymer/calcium phosphate hybrid nanoparticles
EP4295840A3 (en) Glycan polymers and related methods thereof
JP2012513504A5 (tr)
EP4338799A3 (en) Tumor infiltrating lymphocytes and methods of therapy
UA106570C2 (uk) Суміші полімолочної кислоти й розчинного у воді полімеру
PT2274353E (pt) Policarbodiimidas
ATE485407T1 (de) Polymerfasern und verfahren zu ihrer herstellung
MX2019007602A (es) Nanoparticulas recubiertas para su uso para modular la polarizacion electrica de neuronas.
EP2518509A3 (en) Molecular prognosis and classification of malignant melanoma based upon markers selected from the list consisting of RGS1, NCOA3, SPP1, PHIP.
CA2835730C (en) Molecular markers in prostate cancer
ATE501226T1 (de) Wässrige dispersionen aufweisend mindestens ein alkyd-harz und mindestens ein polymerisat mit mindestens einem (meth)acrylat-segment
WO2014109842A3 (en) Nanotechnology based medicine for biodefense
MY159189A (en) Polymer with salt groups and antifouling coating composition comprising said polymer
FR3047244B1 (fr) Copolymere amphiphile dibloc et son utilisation pour la fabrication de membranes polymeriques de filtration
WO2013112381A3 (en) New class of anti-adhesion hydrogels with healing aspects
WO2018050942A8 (es) Nanopartículas con interiores protegidos, y métodos de uso de las mismas
MX339843B (es) Composiciones cosmeticas con facil lavado de larga duracion.
MX2023005539A (es) Nanoestructuras plasmonicas funcionalizadas.
TR201909251T4 (tr) Silil ester grupları içeren bir polimeri ve kuvaterner amonyum/fosfonyum sülfonat grupları içeren bir polimeri ihtiva eden çürüme önleyici kaplama bileşimi.
MX2018000719A (es) Resina autorreparante.
PH12018500453A1 (en) Polymeric microparticles as filtration and/or clarifying aids in phosphoric acid production
Mawlood The effect of adding citrus bergamia essential oil on Candida albicans Activity and some properties of a heat cured acrylic resin material